U.S. Markets open in 7 hrs 53 mins

Vical Incorporated (VICL)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.48+0.03 (+1.22%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close2.45
Bid0.00 x
Ask0.00 x
Day's Range2.45 - 2.52
52 Week Range2.05 - 4.59
Avg. Volume83,850
Market Cap27.52M
PE Ratio (TTM)-2.77
EPS (TTM)-0.89
Earnings DateMay 11, 2017 - May 12, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.10
Trade prices are not sourced from all markets
  • GlobeNewswire11 days ago

    Vical to Provide Company Update at the 2017 BIO International Convention

    SAN DIEGO, June 15, 2017-- Vical Incorporated announced today that the company will provide an overview of its technologies, development programs, and outlook at 4:15 p.m. PT on Wednesday, June 21, at ...

  • Capital Cube12 days ago

    ETFs with exposure to Vical, Inc. : June 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vical, Inc. :VICL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cube14 days ago

    Vical, Inc. :VICL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Vical, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Vical, Inc. – CytRx Corporation, Newlink Genetics Corporation, Chimerix, Inc., Agenus Inc., Celldex Therapeutics, Inc., Pfizer Inc., Merck & Co., Inc. and Bristol-Myers Squibb Company (CYTR-US, NLNK-US, CMRX-US, AGEN-US, ... Read more (Read more...)